Gamida Cell Ltd. (GMDA) Q1 2022 Earnings Call Transcript
GMDA earnings call for the period ending March 31, 2022.
Source: fool.com
Page 28 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gamida Cell Today - Breaking & Trending Today
2022-05-05 | NDAQ:ORGO | Press Release | Organogenesis Holdings Inc.
(2022-05-05 | NDAQ:ORGO) Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors
Source: stockhouse.com
Gamida Cell jumps on FDA lymphoma treatment clearance
GDA-201 is an off-the-shelf cell therapy candidate for the treatment of patients with follicular and diffuse large B cell lymphomas.
Source: globes.co.il
Gamida Cell Ltd. (NASDAQ:GMDA) Expected to Post Earnings of -$0.34 Per Share
Equities research analysts expect that Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) will post earnings of ($0.34) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Gamida Cell’s earnings, with the highest EPS estimate coming in at ($0.30) and the lowest estimate coming in at ($0.38). Gamida Cell also […]
Source: etfdailynews.com
Gamida Cell (NASDAQ:GMDA) and Passage Bio (NASDAQ:PASG) Head to Head Analysis
Gamida Cell (NASDAQ:GMDA – Get Rating) and Passage Bio (NASDAQ:PASG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]
Source: etfdailynews.com